Tom Shroder, AlterNetIn the past decade, after thirty years in the deep freeze, research into the medicinal use of psychedelic drugs, ranging from psilocybin to Ketamine, and from MDMA to LSD, has begun to accelerate. FDA-approved pilot studies and clinical trials using the drugs under controlled conditions and in combination with talk therapy have shown they could be used safely, delivering promising results in a wide range of tough-to-treat maladies, including opiate and tobacco addictio [...]
View Article Here
Read More
The High Cost of Low Trust
{mainvote}
Posted on May 11, 2011 by BVG Janaka dasa das
Each week we will be asking Dr. Stephen Covey to comment on common questions.
Most organizations have no clue of the enormous cost of low trust, and because most executives have n...
View Article Here Read More